XML 16 R6.htm IDEA: XBRL DOCUMENT v3.22.2
CONDENSED CONSOLIDATED STATEMENT OF STOCKHOLDERS' EQUITY - USD ($)
$ in Thousands
Total
Total Radnet, Inc.'s Equity
Common Stock
Common Stock
DeepHealth, Inc.
Additional Paid-In Capital
Accumulated Other Comprehensive Loss
Accumulated Deficit
Noncontrolling Interests
Beginning balance (in shares) at Dec. 31, 2020     51,640,537          
Beginning balance, value at Dec. 31, 2020 $ 258,303 $ 165,743 $ 5   $ 307,788 $ (24,051) $ (117,999) $ 92,560
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Issuance of common stock upon exercise of options (in shares)     2,500          
Issuance of common stock upon exercise of options 26 26     26      
Issuance of common stock under the equity compensation plan (in shares)     1,033,358 1,635        
Stock-based compensation expense 17,145 17,145     17,145      
Purchase of noncontorlling interests (4) (4)     (4)      
Contribution from noncontrolling partner 123             123
Change in cumulative foreign currency translation adjustment (21) (21)       (21)    
Change in fair value of cash flow hedge from prior periods reclassified to earnings, net of taxes 1,845 1,845       1,845    
Other 0 (1)     (1)     1
Net income 21,862 12,331         12,331 9,531
Ending balance (in shares) at Jun. 30, 2021     52,678,030          
Ending balance, value at Jun. 30, 2021 299,279 197,064 $ 5   324,954 (22,227) (105,668) 102,215
Beginning balance (in shares) at Mar. 31, 2021     52,340,856          
Beginning balance, value at Mar. 31, 2021 281,358 184,358 $ 5   316,032 (23,138) (108,541) 97,000
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Issuance of common stock upon exercise of options (in shares)     2,500          
Issuance of common stock upon exercise of options 26 26     26      
Issuance of common stock under the equity compensation plan (in shares)     333,533 1,141        
Stock-based compensation expense 8,897 8,897     8,897      
Change in cumulative foreign currency translation adjustment (9) (9)       (9)    
Change in fair value of cash flow hedge from prior periods reclassified to earnings, net of taxes 920 920       920    
Other 0 (1)     (1)     1
Net income 8,087 2,873         2,873 5,214
Ending balance (in shares) at Jun. 30, 2021     52,678,030          
Ending balance, value at Jun. 30, 2021 299,279 197,064 $ 5   324,954 (22,227) (105,668) 102,215
Beginning balance (in shares) at Dec. 31, 2021     53,548,227          
Beginning balance, value at Dec. 31, 2021 346,157 228,904 $ 5   342,592 (20,421) (93,272) 117,253
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Issuance of common stock under the equity compensation plan (in shares)     683,077 965,969        
Stock-based compensation expense 15,494 15,494     15,494      
Issuance of common stock for sale of unregistered securities for acquisition (in shares)     2,106,292          
Issuance of common stock for sale of unregistered securities for acquisition 56,470 56,470     56,470      
Contribution from noncontrolling partner 10,673             10,673
Sale of economic interests in majority owned subsidiary, net of taxes 4,582 4,582     4,582     0
Change in cumulative foreign currency translation adjustment (6,030) (6,030)       (6,030)    
Change in fair value of cash flow hedge from prior periods reclassified to earnings, net of taxes 1,847 1,847       1,847    
Other (2) (2)     (2) 1 (1)  
Net income 22,194 10,918         10,918 11,276
Ending balance (in shares) at Jun. 30, 2022     57,303,565          
Ending balance, value at Jun. 30, 2022 451,385 312,183 $ 5   419,136 (24,603) (82,355) 139,202
Beginning balance (in shares) at Mar. 31, 2022     56,197,826          
Beginning balance, value at Mar. 31, 2022 421,450 298,847 $ 5   409,863 (20,761) (90,260) 122,603
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Issuance of common stock under the equity compensation plan (in shares)     152,889 952,850        
Stock-based compensation expense 4,693 4,693     4,693      
Sale of economic interests in majority owned subsidiary, net of taxes 4,582 4,582     4,582      
Change in cumulative foreign currency translation adjustment (4,766) (4,766)       (4,766)    
Change in fair value of cash flow hedge from prior periods reclassified to earnings, net of taxes 924 924       924    
Other (2) (2)     (2)      
Net income 13,831 7,905         7,905 5,926
Ending balance (in shares) at Jun. 30, 2022     57,303,565          
Ending balance, value at Jun. 30, 2022 $ 451,385 $ 312,183 $ 5   $ 419,136 $ (24,603) $ (82,355) $ 139,202